Lake Street Private Wealth LLC Sells 1,822 Shares of Colgate-Palmolive (NYSE:CL)

Lake Street Private Wealth LLC decreased its position in shares of Colgate-Palmolive (NYSE:CL) by 44.9% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,236 shares of the company’s stock after selling 1,822 shares during the quarter. Lake Street Private Wealth LLC’s holdings in Colgate-Palmolive were worth $203,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CL. Canoe Financial LP lifted its holdings in Colgate-Palmolive by 5.0% in the fourth quarter. Canoe Financial LP now owns 88,646 shares of the company’s stock valued at $8,059,000 after buying an additional 4,200 shares during the period. Folger Nolan Fleming Douglas Capital Management Inc. lifted its stake in shares of Colgate-Palmolive by 6.1% in the 4th quarter. Folger Nolan Fleming Douglas Capital Management Inc. now owns 5,714 shares of the company’s stock valued at $519,000 after purchasing an additional 330 shares during the period. Arthur M. Cohen & Associates LLC boosted its position in shares of Colgate-Palmolive by 8.2% during the 4th quarter. Arthur M. Cohen & Associates LLC now owns 2,650 shares of the company’s stock valued at $241,000 after purchasing an additional 200 shares in the last quarter. Brooklyn Investment Group increased its holdings in Colgate-Palmolive by 7.9% in the fourth quarter. Brooklyn Investment Group now owns 5,564 shares of the company’s stock worth $506,000 after purchasing an additional 405 shares in the last quarter. Finally, Sax Wealth Advisors LLC lifted its stake in Colgate-Palmolive by 432.0% in the fourth quarter. Sax Wealth Advisors LLC now owns 22,764 shares of the company’s stock valued at $2,069,000 after buying an additional 18,485 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $88.79 on Friday. The stock has a market cap of $72.55 billion, a P/E ratio of 25.44, a P/E/G ratio of 3.01 and a beta of 0.44. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The company’s 50 day moving average price is $92.20 and its two-hundred day moving average price is $97.74. Colgate-Palmolive has a 52 week low of $79.69 and a 52 week high of $109.30.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.25%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. JPMorgan Chase & Co. reduced their price objective on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a research report on Thursday. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. UBS Group cut their price objective on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research report on Thursday. Piper Sandler decreased their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. Finally, Wells Fargo & Company cut their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $101.11.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.37% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.